Skip to content

SG&A at other companies

Biogen logo
BiogenBIIB
$607.3M+6.1%
AbbVie logo
AbbVieABBV
$3.58B+8.7%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$10.98M-42.4%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$171.02M+35.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$73.66M-3.8%
uniQure logo
uniQureQURE
$20.07M+84.0%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's SG&A?
Alpha Cognition (ACOG) reported SG&A of $10.26M in Q1 2026.
How has Alpha Cognition's SG&A changed year-over-year?
Alpha Cognition's SG&A increased by 101.5% year-over-year, from $5.09M to $10.26M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.